Equine Veterinary Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F

Description

The Global Equine Veterinary Therapeutics Market, valued at USD 1.82 Billion in 2024, is projected to experience a CAGR of 7.21% to reach USD 2.76 Billion by 2030. The Global Equine Veterinary Therapeutics Market encompasses pharmaceuticals, vaccines, and diagnostic tools specifically developed to maintain and restore the health of horses. This market's growth is primarily driven by the increasing prevalence of various equine diseases, a heightened awareness among horse owners regarding animal welfare and preventive care, and the sustained expansion of equestrian sports globally.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.82 Billion
Market Size 2030	USD 2.76 Billion
CAGR 2025-2030	7.21%
Fastest Growing Segment	Anti-Inflammatory
Largest Market	North America

Key Market Drivers

Increased equine health awareness and the rising adoption of preventative care significantly drive the global equine veterinary therapeutics market. Horse owners are increasingly recognizing the long-term benefits of proactive health management, leading to greater demand for vaccines, parasiticides, and nutritional supplements. This shift towards preventative strategies minimizes the incidence and severity of diseases, thereby necessitating a steady supply of efficacious therapeutics for routine immunization and health maintenance.

Key Market Challenges

The persistent shortage of skilled equine veterinarians represents a significant impediment to the expansion of the Global Equine Veterinary Therapeutics Market. A limited number of practitioners directly restricts the accessibility of essential veterinary services, including routine health examinations, disease diagnosis, and the administration of critical pharmaceuticals and vaccines. This constraint means that even with advanced therapeutics available, their deployment to the substantial equine population is bottlenecked by the human resources required for delivery and oversight.

Key Market Trends

The shift towards personalized equine treatment plans represents a critical evolution, moving beyond standardized protocols to cater to the individual physiological and genetic makeup of each horse. This approach leverages advanced diagnostics, including genetic testing, to inform targeted therapeutic interventions.

Key Market Players

Merck & Co., Inc.
Thermo Fisher Scientific Inc (Affymetrix)
Elanco Animal Health Inc.
Zoetis Services LLC
Farnam Companies, Inc.

Report Scope:

In this report, the Global Equine Veterinary Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Veterinary Therapeutics Market, By Drugs:

Anti-Inflammatory
Anti-Infective
Parasiticides
Others

Equine Veterinary Therapeutics Market, By Route of Administration:

Oral
Parental
Topical

Equine Veterinary Therapeutics Market, By Distribution Channel:

Veterinary Hospital
Veterinary Clinics
Pharmacies and drugstores
E-commerce
Other

Equine Veterinary Therapeutics Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Equine Veterinary Therapeutics Market.

Available Customizations:

Global Equine Veterinary Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Veterinary Therapeutics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Drugs (Anti-Inflammatory, Anti-Infective, Parasiticides, Others)
- 5.2.2. By Route of Administration (Oral, Parental, Topical)
- 5.2.3. By Distribution Channel (Veterinary Hospital, Veterinary Clinics, Pharmacies and drugstores, E-commerce, Other)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Equine Veterinary Therapeutics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Drugs
- 6.2.2. By Route of Administration
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Equine Veterinary Therapeutics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Drugs
    - 6.3.1.2.2. By Route of Administration
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Equine Veterinary Therapeutics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Drugs
    - 6.3.2.2.2. By Route of Administration
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Equine Veterinary Therapeutics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Drugs
    - 6.3.3.2.2. By Route of Administration
    - 6.3.3.2.3. By Distribution Channel

7. Europe Equine Veterinary Therapeutics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Drugs
- 7.2.2. By Route of Administration
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Equine Veterinary Therapeutics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Drugs
    - 7.3.1.2.2. By Route of Administration
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. France Equine Veterinary Therapeutics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Drugs
    - 7.3.2.2.2. By Route of Administration
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. United Kingdom Equine Veterinary Therapeutics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Drugs
    - 7.3.3.2.2. By Route of Administration
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. Italy Equine Veterinary Therapeutics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Drugs
    - 7.3.4.2.2. By Route of Administration
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Equine Veterinary Therapeutics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Drugs
    - 7.3.5.2.2. By Route of Administration
    - 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Equine Veterinary Therapeutics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Drugs
- 8.2.2. By Route of Administration
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Equine Veterinary Therapeutics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Drugs
    - 8.3.1.2.2. By Route of Administration
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Equine Veterinary Therapeutics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Drugs
    - 8.3.2.2.2. By Route of Administration
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Equine Veterinary Therapeutics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Drugs
    - 8.3.3.2.2. By Route of Administration
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Equine Veterinary Therapeutics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Drugs
    - 8.3.4.2.2. By Route of Administration
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Equine Veterinary Therapeutics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Drugs
    - 8.3.5.2.2. By Route of Administration
    - 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Equine Veterinary Therapeutics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Drugs
- 9.2.2. By Route of Administration
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Equine Veterinary Therapeutics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Drugs
    - 9.3.1.2.2. By Route of Administration
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. UAE Equine Veterinary Therapeutics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Drugs
    - 9.3.2.2.2. By Route of Administration
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. South Africa Equine Veterinary Therapeutics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Drugs
    - 9.3.3.2.2. By Route of Administration
    - 9.3.3.2.3. By Distribution Channel

10. South America Equine Veterinary Therapeutics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Drugs
- 10.2.2. By Route of Administration
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Equine Veterinary Therapeutics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Drugs
    - 10.3.1.2.2. By Route of Administration
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Colombia Equine Veterinary Therapeutics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Drugs
    - 10.3.2.2.2. By Route of Administration
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. Argentina Equine Veterinary Therapeutics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Drugs
    - 10.3.3.2.2. By Route of Administration
    - 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Equine Veterinary Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Merck & Co., Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific Inc (Affymetrix)
15.3. Elanco Animal Health Inc.
15.4. Zoetis Services LLC
15.5. Farnam Companies, Inc.